Anebulo Pharmaceuticals Files 8-K
Ticker: ANEB · Form: 8-K · Filed: Sep 12, 2025 · CIK: 1815974
| Field | Detail |
|---|---|
| Company | Anebulo Pharmaceuticals, Inc. (ANEB) |
| Form Type | 8-K |
| Filed Date | Sep 12, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-update, filing
TL;DR
Anebulo Pharma filed an 8-K on 9/12/25 with updated corporate info.
AI Summary
Anebulo Pharmaceuticals, Inc. filed an 8-K on September 12, 2025, reporting other events and financial statements. The filing details the company's principal executive offices located at 1017 Ranch Road 620 South, Suite 107, Lakeway, TX 78734, and its telephone number is 737 203 5270. The company is incorporated in Delaware and its fiscal year ends on June 30.
Why It Matters
This 8-K filing provides updated corporate information and signals ongoing regulatory compliance for Anebulo Pharmaceuticals.
Risk Assessment
Risk Level: low — This filing is a routine corporate update and does not appear to contain significant new risks.
Key Players & Entities
- Anebulo Pharmaceuticals, Inc. (company) — Registrant
- September 12, 2025 (date) — Date of earliest event reported
- 1017 Ranch Road 620 South, Suite 107, Lakeway, TX 78734 (location) — Address of Principal Executive Offices
- 737 203 5270 (phone_number) — Registrant's Telephone Number
- Delaware (jurisdiction) — State of Incorporation
FAQ
What is the primary purpose of this 8-K filing for Anebulo Pharmaceuticals?
The primary purpose of this 8-K filing is to report 'Other Events' and 'Financial Statements and Exhibits' as of September 12, 2025.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on September 12, 2025.
Where are Anebulo Pharmaceuticals' principal executive offices located?
Anebulo Pharmaceuticals' principal executive offices are located at 1017 Ranch Road 620 South, Suite 107, Lakeway, TX 78734.
In which state is Anebulo Pharmaceuticals incorporated?
Anebulo Pharmaceuticals is incorporated in Delaware.
What is the fiscal year end for Anebulo Pharmaceuticals?
Anebulo Pharmaceuticals' fiscal year ends on June 30.
Filing Stats: 461 words · 2 min read · ~2 pages · Grade level 12.3 · Accepted 2025-09-12 08:00:27
Filing Documents
- form8-k.htm (8-K) — 42KB
- ex99-1.htm (EX-99.1) — 12KB
- ex99-1_001.jpg (GRAPHIC) — 5KB
- 0001493152-25-013133.txt ( ) — 231KB
- aneb-20250912.xsd (EX-101.SCH) — 3KB
- aneb-20250912_lab.xml (EX-101.LAB) — 33KB
- aneb-20250912_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ANEBULO PHARMACEUTICALS, INC. Date: September 12, 2025 By: /s/ Richard Anthony Cunningham Richard Anthony Cunningham Chief Executive Officer ( Principal Executive Officer ) -3-